Top Markets
#1 GoPlus Security GoPlus Security +31.51%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.70%
#3 Status Status +17.55%
#4 Wrapped NXM Wrapped NXM +14.47%
#5 BankrCoin BankrCoin +11.13%
#6 Pons Pons +10.73%
#7 Bedrock Bedrock +10.01%
#8 Ontology Gas Ontology Gas +9.25%
#9 DMT-NAT DMT-NAT +8.78%
#10 o1.exchange o1.exchange +7.41%
Coin of the day
GoPlus Security GoPlus Security
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
Rang in Aktien #34084
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
Aktienkurs
$0.02082992
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.27M
Veränderung (1 Tag)
-3.31%
Veränderung (1 Jahr)
-51.62%
Land
RU
Handel PJSC Pharmsynthez (LIFE)

Kategorie

Healthcare
Kursverlauf für PJSC Pharmsynthez (LIFE)
Höchster Schlusskurs: $0.02 am 2026-08-01

Niedrigster Schlusskurs: $0.76 am 2010-11-01
Kursverlauf der Aktie von PJSC Pharmsynthez von 2010 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -9.44%
2025 30.97%
2024 -44.82%
2023 -11.95%
2022 -18.74%
2021 -19.66%
2020 45.23%
2019 -22.41%
2018 -56.43%
2017 -26.82%
2016 72.01%
2015 -33.83%
2014 -51.22%
2013 7.71%
2012 -30.67%
2011 -14.49%
2010 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE